These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15121766)

  • 41. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.
    Grégoire S; Yang XJ
    Mol Cell Biol; 2005 Mar; 25(6):2273-87. PubMed ID: 15743823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2.
    Nakagawa O; Arnold M; Nakagawa M; Hamada H; Shelton JM; Kusano H; Harris TM; Childs G; Campbell KP; Richardson JA; Nishino I; Olson EN
    Genes Dev; 2005 Sep; 19(17):2066-77. PubMed ID: 16140986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations within the conserved MADS box of the D-MEF2 muscle differentiation factor result in a loss of DNA binding ability and lethality in Drosophila.
    Nguyen T; Wang J; Schulz RA
    Differentiation; 2002 Oct; 70(8):438-46. PubMed ID: 12366381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purkinje fibers of the avian heart express a myogenic transcription factor program distinct from cardiac and skeletal muscle.
    Takebayashi-Suzuki K; Pauliks LB; Eltsefon Y; Mikawa T
    Dev Biol; 2001 Jun; 234(2):390-401. PubMed ID: 11397008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of local statistical significance of patterns in Markov sequences with application to promoter element identification.
    Huang H; Kao MC; Zhou X; Liu JS; Wong WH
    J Comput Biol; 2004; 11(1):1-14. PubMed ID: 15072685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic testing in cardiovascular diseases.
    Arndt AK; MacRae CA
    Curr Opin Cardiol; 2014 May; 29(3):235-40. PubMed ID: 24717670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drosophila mef2 expression during mesoderm development is controlled by a complex array of cis-acting regulatory modules.
    Nguyen HT; Xu X
    Dev Biol; 1998 Dec; 204(2):550-66. PubMed ID: 9882489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CaM kinase IIdeltaC phosphorylation of 14-3-3beta in vascular smooth muscle cells: activation of class II HDAC repression.
    Ellis JJ; Valencia TG; Zeng H; Roberts LD; Deaton RA; Grant SR
    Mol Cell Biochem; 2003 Jan; 242(1-2):153-61. PubMed ID: 12619878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and 1q12-q23.
    Hobson GM; Krahe R; Garcia E; Siciliano MJ; Funanage VL
    Genomics; 1995 Oct; 29(3):704-11. PubMed ID: 8575763
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1.
    Yang CC; Ornatsky OI; McDermott JC; Cruz TF; Prody CA
    Nucleic Acids Res; 1998 Oct; 26(20):4771-7. PubMed ID: 9753748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MEF2 proteins, including MEF2A, are expressed in both muscle and non-muscle cells.
    Dodou E; Sparrow DB; Mohun T; Treisman R
    Nucleic Acids Res; 1995 Nov; 23(21):4267-74. PubMed ID: 7501445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular genetics: paying individual dividends.
    McNally E
    Sci Transl Med; 2014 Jun; 6(239):239ed12. PubMed ID: 24898741
    [No Abstract]   [Full Text] [Related]  

  • 53. Genetics and cardiovascular disease.
    Loddo I; Barbera F; Di Gesaro G; Cutrupi MC; Calabrò MP; Ceravolo G; Salpietro C; Gramaglia SMC; Ceravolo A; Concolino D; De Sarro R; Cuppari C; Gitto E; Clemenza F; Di Carlo D
    J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 2):17-22. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY. PubMed ID: 33000595
    [No Abstract]   [Full Text] [Related]  

  • 54. Another casualty of sibling fixed-effects analysis of education and health: an informative null, or null information?
    Gilman SE; Loucks EB
    Soc Sci Med; 2014 Oct; 118():191-3. PubMed ID: 25138687
    [No Abstract]   [Full Text] [Related]  

  • 55. Genetic factors in cardiovascular diseases.
    MCKUSICK VA
    J Am Geriatr Soc; 1961 Jun; 9():465-76. PubMed ID: 13774056
    [No Abstract]   [Full Text] [Related]  

  • 56. Cardiovascular genetics--two steps forward, one step back.
    Harrap SB
    Ann Acad Med Singap; 2007 Jun; 36(6):373-5. PubMed ID: 17597957
    [No Abstract]   [Full Text] [Related]  

  • 57. Genetics and cardiovascular disease: Design and development of a DNA biobank.
    Jayasinghe SR; Mishra A; Van Daal A; Kwan E
    Exp Clin Cardiol; 2009; 14(3):33-7. PubMed ID: 20098575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative trait locus analysis for hemostasis and thrombosis.
    Sa Q; Hart E; Hill AE; Nadeau JH; Hoover-Plow JL
    Mamm Genome; 2008 Jun; 19(6):406-12. PubMed ID: 18787898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular genetics: are we there yet?
    Sturm AC
    J Med Genet; 2004 May; 41(5):321-3. PubMed ID: 15121766
    [No Abstract]   [Full Text] [Related]  

  • 60. Heart attack gene discovered; prevention steps remain crucial.
    Heart Advis; 2004 Feb; 7(2):2. PubMed ID: 15106568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.